Prolysis Ltd.

The Wellcome Trust will continue to help fund the early stages of drug discovery for another five years by extending its Seeding Drug Discovery initiative with a further £110 million. The trust set up

Biota Holdings has acquired early stage antibacterial programmes from the UK firm Prolysis and MaxThera of the US, in an effort to extend its research interests beyond antivirals and into the wider an

Hitting at the heart of bacteria Oxford University Begbroke Business & Science Park Sandy Lane, Yarnton Oxfordshire, OX5 1PF, UK Phone: +44 (0) 1865 854700 Fax: +44 (0) 1865 854799 Web Site: www.proly

The rise in bacterial resistance has prompted a plethora of creative approaches to developing antibiotics. Only a few novel antibiotics have reached the market in the last 20 years or more, including